Stay updated with breaking news from Highly Selective. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 -- HUTCHMED Limited today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib, as well as new...
Investegate announcements from HUTCHMED Data to be Presented at EHA2024 Congress
In response to the Supreme Court's affirmative action ruling, colleges are expanding financial aid, boosting socioeconomic diversity efforts. Read to learn more.
An app called Blinkist costs $12.99 a month and is designed to help you achieve your New Year resolution to “read” more books. Blinkist offers brief summaries that give the
'Safety profile is one of the real advantages' of non-covalent BTK inhibitor, says panelist